Nebulised RPL554 was examined in study 1 for safety in 18 healthy men who were randomly assigned ( 1:1:1 ) to receive an inhaled dose of RPL554 ( 0003 mg/kg or 0009 mg/kg ) or placebo by a computer-generated randomisation table .